Dorman Products vs Valvoline
DORM and VVV side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DORM and VVV compare
Valvoline is the larger company, worth 1.2 times as much as Dorman Products ($4.6B against $4.0B).
On earnings, Dorman Products is cheaper: it trades at 20.0× trailing earnings, against 45.4× for Valvoline.
Valvoline grew revenue faster over the last twelve months (16.1% versus 2.2% for Dorman Products).
Dorman Products keeps more of each dollar of sales as profit, with a net margin of 9.3% compared with 5.2% at Valvoline.
Dorman Products scores higher on the StockData Score (13 against 7 for Valvoline), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DORM | VVV |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $4.6B |
| Share price | $134.55 | $35.90 |
| Change, 1 year | 0.40% | 14.4% |
| Change, 5 years | 14.0% | −0.50% |
| Beta (5Y) | 0.68 | 0.79 |
| Employees | 300 | 11K |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 5 (better) | 3 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.0× (better) | 45.4× |
| P/S | 1.8× (better) | 2.3× |
| P/B | 2.5× (better) | 11.0× |
| EV/EBITDA | 12.3× (better) | 20.3× |
| P/FCF | 14.7× (better) | 33.9× |
| PEG | 1.00 | – |
| FCF yield | 6.8% (better) | 3.0% |
| Fair value | $113.99 | $17.30 |
| Margin of safety | −18.0% (better) | −107% |
| Growth | ||
| Revenue growth (TTM) | 2.2% | 16.1% (better) |
| Revenue growth, 5Y average | 14.3% | 18.7% (better) |
| Net income growth (TTM) | −18.2% (better) | −63.5% |
| EPS growth (TTM) | −16.3% (better) | −63.3% |
| EPS growth, 5Y average | 15.0% (better) | −0.60% |
| Profitability | ||
| Gross margin | 41.1% (better) | 38.3% |
| Operating margin | 13.3% | 15.3% (better) |
| Net margin | 9.3% (better) | 5.2% |
| FCF margin | 12.4% (better) | 6.9% |
| Return on equity | 13.3% | 27.8% (better) |
| Return on invested capital | 11.5% (better) | 10.9% |
| Financial health | ||
| Debt / equity | 0.28 (better) | 3.84 |
| Net debt / EBITDA | 0.79 (better) | 5.04 |
| Interest coverage | 10.8× | – |
| Current ratio | 3.65 (better) | 0.70 |
| Altman Z-score | 4.95 (better) | 1.85 |
| Piotroski F-score | 8 | 8 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 97.6% | 117% |
| Held by insiders | 8.2% | 0.33% |
| Insider net buying, 12 months | −$1.7M | −$42.4K (better) |
| Short interest, % of float | 5.7% | 11.1% |
Go deeper
- DORM stock overview
- DORM income statement
- DORM valuation and score
- VVV stock overview
- VVV income statement
- VVV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.